Abstract
How and when the known genetic risk allele, apolipoprotein E-ε4 (APOEε4), confers risk to Alzheimer’s disease has yet to be determined. We studied older adults and found that APOEε4 carriers had greater neural activation in the medial frontal and parahippocampal gyrus during a memory task (cluster-corrected p < .01). When compared to a group of younger adults, interactive effects of age and APOEε4 were found in the inferior frontal—anterior temporal region, one of the first areas to develop amyloid plaques in patients with Alzheimer’s disease, and, in the posterior cingulate, one of the earliest areas to show decreased cerebral metabolism in Alzheimer’s disease. Thus, abnormally high activation in fronto-temporal areas are present in both younger and older APOEε4 carriers confronted with a working memory task when compared to non-APOEε4 carriers. This effect, however, appears to diminish with age.
Similar content being viewed by others
References
Anderson, V. C., Litvack, Z. N., & Kaye, J. A. (2005). Magnetic resonance approaches to brain aging and Alzheimer disease-associated neuropathology. Topics in Magnetic Resonance Imaging, 16(6), 439–452.
Bartres-Faz, D., Serra-Grabulosa, J. M., Sun, F. T., Sole-Padulles, C., Rami, L., Molinuevo, J. L., et al. (2007). Functional connectivity of the hippocampus in elderly with mild memory dysfunction carrying the APOE varepsilon4 allele. Neurobiology of Aging.
Bassett, S. S., Yousem, D. M., Cristinzio, C., Kusevic, I., Yassa, M. A., Caffo, B. S., et al. (2006). Familial risk for Alzheimer’s disease alters fMRI activation patterns. Brain, 129(Pt 5), 1229–1239.
Bondi, M. W., Houston, W. S., Eyler, L. T., & Brown, G. G. (2005). fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology, 64(3), 501–508.
Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., et al. (2000). Patterns of brain activation in people at risk for Alzheimer’s disease. The New England Journal of Medicine, 343(7), 450–456.
Borghesani, P. R., Johnson, L. C., Shelton, A. L., Peskind, E. R., Aylward, E. H., Schellenberg, G. D., et al. (2007). Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers. Neurobiology of Aging.
Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica, 82(4), 239–259.
Buckner, R. L. (2004). Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron, 44(1), 195–208.
Burggren, A. C., Small, G. W., Sabb, F. W., & Bookheimer, S. Y. (2002). Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. American Journal of Geriatric Psychiatry, 10(1), 44–51.
Cabeza, R. (2000). Handbook of functional neuroimaging of cognition. Cambridge: MIT Press.
Cohen, M. S. (1997). Parametric analysis of fMRI data using linear systems methods. Neuroimage, 6(2), 93–103.
Cohen, J. D., MacWhinney, B., Flatt, M., & Provost, J. (1993). PsyScope: a new graphic interactive environment for designing psychology experiments. Behavior Research Methods, Instruments, & Computers, 25(2), 257–271.
Cohen, R. M., Small, C., Lalonde, F., Friz, J., & Sunderland, T. (2001). Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology, 57(12), 2223–2228.
Cohen, R. M., Podruchny, T. A., Bokde, A. L., Carson, R. E., Herscovitch, P., Kiesewetter, D. O., et al. (2003). Higher in vivo muscarinic-2 receptor distribution volumes in aging subjects with an apolipoprotein E-epsilon4 allele. Synapse, 49(3), 150–156.
Cohen, R. M., Carson, R. E., Filbey, F., Szczepanik, J., & Sunderland, T. (2006). Age and APOE-epsilon4 genotype influence the effect of physostigmine infusion on the in-vivo distribution volume of the muscarinic-2-receptor dependent tracer [18F]FP-TZTP. Synapse, 60(1), 86–92.
Cox, R. W. (1996). AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Computers and Biomedical Research, 29(3), 162–173.
Devanand, D. P., Habeck, C. G., Tabert, M. H., Scarmeas, N., Pelton, G. H., Moeller, J. R., et al. (2006). PET network abnormalities and cognitive decline in patients with mild cognitive impairment. Neuropsychopharmacology, 31(6), 1327–1334.
Dickerson, B. C., Salat, D. H., Greve, D. N., Chua, E. F., Rand-Giovannetti, E., Rentz, D. M., et al. (2005). Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology, 65(3), 404–411.
Filbey, F. M., Holroyd, T., Carver, F., Sunderland, T., & Cohen, R. M. (2005). A magnetoencephalography spatiotemporal analysis of neural activities during feature binding. NeuroReport, 16(16), 1747–1752.
Filbey, F. M., Slack, K. J., Sunderland, T. P., & Cohen, R. M. (2006). Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEepsilon4 in young healthy adults. NeuroReport, 17(15), 1585–1590.
Fleisher, A. S., Houston, W. S., Eyler, L. T., Frye, S., Jenkins, C., Thal, L. J., et al. (2005). Identification of Alzheimer disease risk by functional magnetic resonance imaging. Archives of Neurology, 62(12), 1881–1888.
Forman, S. D., Cohen, J. D., Fitzgerald, M., Eddy, W. F., Mintun, M. A., & Noll, D. C. (1995). Improved assessment of significant change in functional magnetic resonance imaging (fMri): use of a cluster size threshold. Magnetic Resonance in Medicine, 33, 636–647.
Greenwood, P. M., Lambert, C., Sunderland, T., & Parasuraman, R. (2005). Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results From the National Institute of Mental Health’s BIOCARD study. Neuropsychology, 19(2), 199–211.
Han, S. D., & Bondi, M. W. (2008). Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimers Dement, 4(4), 251-254.
Han, S. D., Houston, W. S., Jak, A. J., Eyler, L. T., Nagel, B. J., Fleisher, A. S., et al. (2006). Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiol Aging.
Han, S. D., Houston, W. S., Jak, A. J., Eyler, L. T., Nagel, B. J., Fleisher, A. S., et al. (2007). Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiology of Aging, 28(2), 238–247.
Hasselmo, M. E., & Stern, C. E. (2006). Mechanisms underlying working memory for novel information. Trends in Cognitive Sciences, 10(11), 487–493.
Jak, A. J., Houston, W. S., Nagel, B. J., Corey-Bloom, J., & Bondi, M. W. (2007). Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults. Dementia and Geriatric Cognitive Disorders, 23(6), 382–389.
Johnson, S. C., Ries, M. L., Hess, T. M., Carlsson, C. M., Gleason, C. E., Alexander, A. L., et al. (2007). Effect of Alzheimer disease risk on brain function during self-appraisal in healthy middle-aged adults. Archives of General Psychiatry, 64(10), 1163–1171.
Kemppainen, N. M., Aalto, S., Wilson, I. A., Nagren, K., Helin, S., Bruck, A., et al. (2007). PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology, 68(19), 1603–1606.
Logan, J., Fowler, J. S., Ding, Y. S., Franceschi, D., Wang, G. J., Volkow, N. D., et al. (2002). Strategy for the formation of parametric images under conditions of low injected radioactivity applied to PET studies with the irreversible monoamine oxidase A tracers [11C]clorgyline and deuterium-substituted [11C]clorgyline. Journal of Cerebral Blood Flow and Metabolism, 22(11), 1367–1376.
Mitchell, K. J., Johnson, M. K., Raye, C. L., & D’Esposito, M. (2000a). fMRI evidence of age-related hippocampal dysfunction in feature binding in working memory. Brain Research. Cognitive Brain Research, 10(1–2), 197–206.
Mitchell, K. J., Johnson, M. K., Raye, C. L., & D’Esposito, M. (2000b). fMRI evidence of age-related hippocampal dysfunction in feature binding in working memory. Brain Research. Cognitive Brain Research, 10(1–2), 197–206.
Mosconi, L., Brys, M., Switalski, R., Mistur, R., Glodzik, L., Pirraglia, E., et al. (2007). Maternal family history of Alzheimer’s disease predisposes to reduced brain glucose metabolism. Proceedings of the National Academy of Sciences of the United States of America, 104(48), 19067–19072.
Nestor, P. J., Fryer, T. D., Ikeda, M., & Hodges, J. R. (2003a). Retrosplenial cortex (BA 29/30) hypometabolism in mild cognitive impairment (prodromal Alzheimer’s disease). The European Journal of Neuroscience, 18(9), 2663–2667.
Nestor, P. J., Fryer, T. D., Smielewski, P., & Hodges, J. R. (2003b). Limbic hypometabolism in Alzheimer’s disease and mild cognitive impairment. Annals of Neurology, 54(3), 343–351.
Persson, J., Lind, J., Larsson, A., Ingvar, M., Sleegers, K., Van Broeckhoven, C., et al. (2008). Altered deactivation in individuals with genetic risk for Alzheimer’s disease. Neuropsychologia, 46(6), 1679–1687.
Pihlajamaki, M., & Sperling, R. A. (2009). Functional MRI assessment of task-induced deactivation of the default mode network in Alzheimer’s disease and atrisk older individuals. Behavioural Neurology, 21(1), 77–91.
Ranganath, C., & D’Esposito, M. (2005). Directing the mind’s eye: prefrontal, inferior and medial temporal mechanisms for visual working memory. Current Opinion in Neurobiology, 15(2), 175–182.
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., et al. (1996). Preclinical evidence of Alzheimer’s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. The New England Journal of Medicine, 334(12), 752–758.
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., et al. (2005). Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proceedings of the National Academy of Sciences of the United States of America, 102(23), 8299–8302.
Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., et al. (2009). Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America, 106(16), 6820–6825.
Rosen, V. M., Bergeson, J. L., Putnam, K., Harwell, A., & Sunderland, T. (2002). Working memory and apolipoprotein E: what’s the connection? Neuropsychologia, 40(13), 2226–2233.
Roses, A. D. (1996). Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annual Review of Medicine, 47, 387–400.
Roses, A. D. (2006). On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease. Journal of Alzheimer’s Disease, 9(3 Suppl), 361–366.
Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., et al. (2007). Imaging beta-amyloid burden in aging and dementia. Neurology, 68(20), 1718–1725.
Scarmeas, N., & Stern, Y. (2005). fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology, 65(9), 1514–1515. author reply 1514–1515.
Scarmeas, N., Anderson, K. E., Hilton, J., Park, A., Habeck, C., Flynn, J., et al. (2004). APOE-dependent PET patterns of brain activation in Alzheimer disease. Neurology, 63(5), 913–915.
Scarmeas, N., Habeck, C. G., Hilton, J., Anderson, K. E., Flynn, J., Park, A., et al. (2005). APOE related alterations in cerebral activation even at college age. Journal of Neurology, Neurosurgery and Psychiatry, 76, 1440–1444.
Snodgrass, J. G., & Vanderwart, M. (1980). A standardized set of 260 pictures: norms for name agreement, image agreement, familiarity, and visual complexity. Journal of Experimental Psychology, 6(2), 174–215.
Stern, C. E., Sherman, S. J., Kirchhoff, B. A., & Hasselmo, M. E. (2001). Medial temporal and prefrontal contributions to working memory tasks with novel and familiar stimuli. Hippocampus, 11(4), 337–346.
Tisserand, D. J., & Jolles, J. (2003). On the involvement of prefrontal networks in cognitive ageing. Cortex, 39(4-5), 1107–1128.
Tsai, M. S., Tangalos, E. G., Petersen, R. C., Smith, G. E., Schaid, D. J., Kokmen, E., et al. (1994). Apolipoprotein E: risk factor for Alzheimer disease. American Journal of Human Genetics, 54(4), 643–649.
Wishart, H. A., Saykin, A. J., McAllister, T. W., Rabin, L. A., McDonald, B. C., Flashman, L. A., et al. (2006a). Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. Neurology, 67(7), 1221–1224.
Wishart, H. A., Saykin, A. J., Rabin, L. A., Santulli, R. B., Flashman, L. A., Guerin, S. J., et al. (2006b). Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele. The American Journal of Psychiatry, 163(9), 1603–1610.
Acknowledgments
We are grateful to Karen Putnam for managing our blind to the subjects’ genotypes. Also, thanks to Irene Dustin, NP for providing the clinical screens and to Heather Kiefer and Kelly Slack for the data collection.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by NIMH ZO1 MH00330-14
Rights and permissions
About this article
Cite this article
Filbey, F.M., Chen, G., Sunderland, T. et al. Failing Compensatory Mechanisms During Working Memory in Older Apolipoprotein E-ε4 Healthy Adults. Brain Imaging and Behavior 4, 177–188 (2010). https://doi.org/10.1007/s11682-010-9097-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11682-010-9097-9